759 related articles for article (PubMed ID: 25453266)
1. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
3. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
Du Y; Liu M; Gao J; Li Z
Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
[TBL] [Abstract][Full Text] [Related]
4. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression.
Hawa Z; Haque I; Ghosh A; Banerjee S; Harris L; Banerjee SK
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240340
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).
Subramani R; Gangwani L; Nandy SB; Arumugam A; Chattopadhyay M; Lakshmanaswamy R
Int J Oncol; 2015 Oct; 47(4):1203-10. PubMed ID: 26314882
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
8. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
Xia T; Chen XY; Zhang YN
Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
[TBL] [Abstract][Full Text] [Related]
10. Developments in miRNA gene signaling pathways in pancreatic cancer.
Vorvis C; Koutsioumpa M; Iliopoulos D
Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.
Karmakar S; Kaushik G; Nimmakayala R; Rachagani S; Ponnusamy MP; Batra SK
Semin Cancer Biol; 2019 Feb; 54():63-71. PubMed ID: 29199014
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Seyhan AA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
[TBL] [Abstract][Full Text] [Related]
15. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
Khan MA; Azim S; Zubair H; Bhardwaj A; Patel GK; Khushman M; Singh S; Singh AP
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383487
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
Rachagani S; Kumar S; Batra SK
Cancer Lett; 2010 Jun; 292(1):8-16. PubMed ID: 20004512
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].
Ren H; Wang CF
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):903-906. PubMed ID: 33256299
[TBL] [Abstract][Full Text] [Related]
19. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
Song B; Ju J
Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as potential therapeutic targets for pancreatic cancer.
Chu X; Wei D; Liu X; Long D; Tian X; Yang Y
Chin Med J (Engl); 2022 Jan; 135(1):4-10. PubMed ID: 34839317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]